Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial
{{output}}
Background: Data on the effect of mineralocorticoid receptor antagonist therapy on HbA1c levels and new-onset diabetes are conflicting. We aimed to examine the effect of oral finerenone, compared with placebo, on incident diabete... ...
